Patent · US Active

Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use

US11229711B2 · kind B2 · utility

1Cited by
3References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 6, 2014
Grant dateJan 25, 2022
Priority date
Expiry dateNov 5, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/6855
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are antibody-cytotoxin antibody-drug conjugates and related compounds, such as linker-cytotoxin conjugates and the linkers used to make them, and intermediates in their synthesis; compositions; and methods, including methods of treating cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.